Current and future advances in practice: tendinopathies of the shoulder.
Chris LittlewoodMaria MoffattNatasha MaherGreg IrvingPublished in: Rheumatology advances in practice (2023)
Tendinopathies of the shoulder are a burdensome problem. Current treatments include exercise, physical therapies, corticosteroid injections and surgery. However, the clinical outcomes from randomized controlled trials evaluating the effectiveness of these interventions are largely unremarkable. Given the apparent lack of progress in improving clinical outcomes for patients, it is appropriate to consider other avenues. Research has identified a link between lifestyle-related modifiable risk factors, including smoking, overweight and physical inactivity, and the onset and persistence of tendinopathies of the shoulder. Further research is required to understand whether addressing these factors results in better clinical outcomes for patients. Teachable moments and shared decision-making are concepts that could enable clinicians to integrate the assessment and management of these lifestyle factors. Given that these lifestyle factors also increase the risk of developing other common morbidities, including cardiovascular disease, an evolution of routine clinical care in this way could represent an important step forwards.
Keyphrases
- physical activity
- cardiovascular disease
- end stage renal disease
- randomized controlled trial
- ejection fraction
- risk factors
- newly diagnosed
- metabolic syndrome
- healthcare
- weight loss
- palliative care
- peritoneal dialysis
- prognostic factors
- magnetic resonance imaging
- magnetic resonance
- computed tomography
- body mass index
- type diabetes
- coronary artery disease
- smoking cessation
- quality improvement
- clinical trial
- cardiovascular events
- coronary artery bypass
- rotator cuff
- percutaneous coronary intervention
- atrial fibrillation
- double blind